A cohort of healthy elderly individuals aged 80 and older
Official title: The Healthy Elderly Longevity Cohort
Run by Scripps Translational Science Institute · NCT01004133 · Data updated 2026-11-12
This study looks at healthy older adults aged 80 and up to see how their genes affect their health as they age.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 80 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Scripps Translational Science Institute Academic / other |
| Drugs / interventions | doxorubicin |
| Locations | 1 site (La Jolla, California) |
| Status | Recruiting |
| Started | August 2007 |
| Main results expected | January 2030 |
| Study ends | January 2030 |
| Registry record updated | January 17, 2025 |
| Trial ID | NCT01004133 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 80 years or older who are generally healthy or have mild medical conditions associated with aging.
✕Probably not a fit
Patients under 80 years old or those with significant chronic conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on individuals aged 80 and older who are generally healthy or have mild age-related medical conditions. It aims to explore the interplay between genetics and health in the elderly population, leveraging advancements from the human genome project to identify genetic variants associated with health phenotypes. Participants will undergo blood or saliva collection to facilitate genetic analysis. The study seeks to enhance understanding of how genetic factors contribute to maintaining health in older adults.
Why it matters
Potential benefit: If successful, this study could provide insights into the genetic factors that promote healthy aging, potentially leading to improved health strategies for the elderly.
How similar studies have gone: While this study explores a relatively novel approach to understanding health in the elderly, similar studies have shown promise in identifying genetic factors related to aging.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 80 years or older 2. Eligible for blood draw and/or saliva collection 3. Be reliable, cooperative and willing to comply with all protocol-specified procedures 4. Able to understand and grant informed consent 5. Be healthy or have mild medical conditions that may be associated with the normal aging process, including: * Hypertension, well controlled (no more than 3 medications) * Osteoporosis, Osteopenia and/or osteoarthritis * Benign prostatic hypertrophy * Cataracts, Glaucoma, Macular Degeneration * Dyslipidemia * Hypothyroidism * Pre-diabetes/impaired fasting glucose (fasting blood glucose 100-126 mg/dL, if known) Exclusion Criteria: 1. \< 80 years old 2. Participants have been previously enrolled in The Scripps Genebank Healthy Elderly Cohort 3. Treatment with any investigational agents or devices within thirty days preceding enrollment in the study. 4. Self-reported history or current diagnosis of significant chronic conditions including: * Any Cancer (including polycythemia; excluding basal or squamous cell skin cancer). * Coronary Artery Disease/Myocardial Infarction * Stroke/TIA * Deep Vein Thrombosis/Pulmonary Embolus * Chronic Renal Disease/Hemodialysis * Significant Auto-immune/Inflammatory conditions such as (Rheumatoid Arthritis, Lupus, Crohn's, etc. * Alzheimer's/Parkinson's * Diabetes (Hemoglobin A1C \> 6.5 % or fasting glucose \>126 mg/dL or treated with oral diabetic medication or insulin if known) * Aortic or Cerebral Aneurysm 5. Currently taking any of the following medications on a regular basis: * Oral chemotherapeutic agents (ex.: tamoxifen, doxorubicin, mitoxantrone, bleomycin) * Anti-platelet agents, not including aspirin (ex.: clopidogrel/plavix, dipyridamole/aggrenox/persantine, ticlopidine/ticlid) * Cholinesterase inhibitor for Alzheimer's disease (i.e. donepezil/Aricept) * Insulin 6. Subject has a significant medical condition which, in the Investigator's opinion, may interfere with the patient's optimal participation in the study or would potentially confound interpretation of the individual's phenotype.
Where it's running
-
Scripps Translational Science Institute
La Jolla, California, United States Recruiting
Study contacts
- Study coordinator: Sarah Topol, BS
- Email: topol.sarah@scrippshealth.org
- Phone: 858-784-2155
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
-
SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults
A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.